Patients were treated with exenatide (14/23) or liraglutide (9/23) and GLP-1 RAs treatment was again connected to a wide range of weight loss, from 1.5 to 16 kg/m 2 in 10/14 cases, and an HbA1c improvement in 19/23 cases, without reported serious side effects (23)
Yes with proper oversight
Tirzepatide: Complete 2026 Comparison Last reviewed and updated: May 5, 2026 medically reviewed by Dr
Okuda S, Nishiyama N, Saito H, Katsuki H
Dahl et al., 2019), and wildtype IDH1 overexpression fully rescued the phenotype, suggesting the observations are not due to off-target effects ( Fig
If you suffer from conditions like IBS (Irritable Bowel Syndrome) or other gastrointestinal issues, BPC-157 may offer additional benefits beyond tissue healing